. Author manuscript; available in PMC: 2017 Mar 1.

Published in final edited form as: Ann Hematol. 2016 Jan 9;95(4):575–580. doi: 10.1007/s00277-016-2588-z

Table 2.

Types of hematological malignancies identified

Hematologic neoplasm	Cases n (%)	D-SPEP n (%)	F-SPEP n (%)	Subtypes (n)	Median nadir CD4: cells/ul (IQ range)^a	Median CD4 within 6 months of diagnosis (IQ range)^a	Median HIV VL within 6 months of diagnosis copies/ ml (IQ range)^a
Plasma cell neoplasms	6 (2.6)	5 (83.3)	0	Multiple myeloma (4) Immature plasma cell tumor (2)	224 (60–486)	282 (146–720)	245 (47–2947)
High grade lymphomas	199 (86.9)	0	12 (6)	DLBCL including primary CNS lymphoma (106)	80 (23–174)	124 (50–216)	28,521 (545–221,881)
				Hodgkin's lymphoma (32)	126 (50–276)	282 (81–391)	1013 (75–115,562)
				Burkitts lymphoma (29)	178 (66–230)	256 (163–401)	18,230 (2015–97,220)
				High grade B cell non–Hodgkin’s lymphoma (15)	155 (71–253)	219 (166–429)	25,400 (1944–59,871)
				Plasmablastic lymphoma (8)	143 (63–247)	136 (100–221)	54,076 (28,690–144,823)
				DLBCL/Burkitts overlap (3)
				Primary effusion lymphoma (2)
				Aggressive T cell non–Hodgkin’s lymphoma (2)
				Extranodal NK/T cell lymphoma (1)
				Anaplastic large cell B cell lymphoma (1)
Low grade lymphomas	11 (4.8)	0	0	Marginal zone lymphoma (6)	255 (144–302)	332 (263–500)	16,611 (460–18,263)
				Follicular lymphoma (2)
				Mycosis fungoides (2)
				Chronic lymphocytic leukemia (1)
Acute leukemias and myelodysplasia	8 (3.5)	0	0	Acute myeloid leukemia (5)	85 (32–798)	469 (83–2752)	75 (75–346,315)
				Acute lymphoblastic leukemia (2)
				Myelodysplasia (1)
Myeloproliferative neoplasms	3 (1.3)	0	0	Chronic myelomonocytic leukemia (2)
				Chronic myeloid leukemia (1)
Dendritic cell neoplasms	2 (0.9)	0	0	Blastic plasmacytoid dendritic cell neoplasm (1)
				Follicular dendritic cell neoplasm (1)

Data on median and IQ range for CD4 and VL results provided in categories of neoplasms where more than three patients were identified